Improving survival following AIDS in Australia, 1991–1996
- 1 October 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (15) , 2349-2354
- https://doi.org/10.1097/00002030-200010200-00016
Abstract
Objective To describe the pattern of survival following AIDS. Design National surveillance for AIDS diagnoses. Methods AIDS cases in adults/adolescents (aged 13 years or older at AIDS diagnosis) and deaths following AIDS were notified to the national HIV surveillance centre by the diagnosing doctor through State/Territory health authorities. The date of last medical contact for each case living with AIDS was updated annually. Results By 30 June 1999, 4814 AIDS cases, diagnosed in Australia in 1991–1996, and 3193 deaths following AIDS had been notified to the National AIDS Registry. Median survival following AIDS was 17.7 months. Survival following AIDS increased from 16.0 months in 1991 to 27.7 months in 1996. Factors independently associated with improved survival were year of AIDS diagnosis, late HIV diagnosis, CD4+ cell count greater than 50 × 106 cells/l, age of less than 45 years and presentation with Pneumocystis carinii pneumonia only or Kaposi's sarcoma only. The risk of death declined over time when the initial AIDS-defining illness was Pneumocystis carinii pneumonia only [adjusted hazard ratio (AHR) = 0.91, P < 0.0005]; other opportunistic infections (AHR, 0.88;P < 0.0005); Kaposi's sarcoma only (AHR, 0.92;P = 0.025); and central nervous system conditions (HIV encephalopathy, cryptococcosis, toxoplasmosis) (AHR, 0.92;P = 0.012). No time trend was observed for survival following diagnoses of non-Hodgkin's lymphoma or other multiple illnesses. Conclusions Survival following AIDS has improved in Australia, especially among cases diagnosed in 1995 and 1996. Temporal improvements in survival following AIDS were coincident with the introduction of combination antiretroviral treatment for HIV infection and suggest that treatment is effective in limiting disease progression among people with advanced HIV infection.Keywords
This publication has 14 references indexed in Scilit:
- Changes in survival among people with AIDS in Lazio, Italy from 1993 to 1998AIDS, 1999
- Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosisAIDS, 1999
- Combination Antiretroviral Therapy and Recent Declines in AIDS Incidence and MortalityThe Journal of Infectious Diseases, 1999
- Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapiesAIDS, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individualsThe Lancet, 1996
- The role of initial AIDS-defining illness in survival following AIDSAIDS, 1995